Memorial Sloan Kettering Cancer Center (MSK) and SOPHiA GENETICS decentralize MSK-ACCESS for liquid biopsy in the Middle East; region-wide access to genomic testing
Memorial Sloan Kettering Cancer Center (MSK) and SOPHiA GENETICS decentralize MSK-ACCESS for liquid biopsy in the Middle East; region-wide access to genomic testing Scaling Liquid Biopsy Innovation Across the Middle East with MSK-ACCESS™ powered with SOPHiA DDM™ - SOPHiA GENETICS Scaling Liquid Biopsy Innovation Across the Middle East with MSK-ACCESS™ powered with SOPHiA DDM™ Home Scaling Liquid Biopsy Innovation Across the Middle East with MSK-ACCESS™ powered with SOPHiA DDM™ From genomic innovation to real-world implementation: exploring the future of liquid biopsy and precision oncology across the Middle East. ...